Tuesday, October 28, 2008

Merck's Antiretroviral Isentress More Efficient In Suppressing HIV

Merck's Antiretroviral Isentress More Efficient In Suppressing HIV

Merck's antiretroviral drug Isentress suppresses levels of HIV in previously untreated patients better than the company's antiretroviral efavirenz, according to research presented Sunday at a meeting of the American Society of Microbiology and the Infectious Diseases Society of America, Reuters reports. According to Phase III clinical trial results, Isentress -- known generically as raltegravir -- reduced HIV viral loads to undetectable levels in 86% of patients compared with 82% of patients treated with efavirenz (Fox, Reuters, 10/26).

read more



Funding Shortage Hindering HIV/AIDS Programs In Burundi

HIV/AIDS programs in Burundi are unable to expand their services because of a shortage of government funding, IRIN/PlusNews reports. The National AIDS Control Council of Burundi said that in 2008, the government experienced an $11 million shortfall in the $28 million budget needed to address HIV/AIDS in the country. In addition, there was an $83 million shortage in funding needed to fulfill the national AIDS strategic plan from 2007 to 2011.

read more



Spending On Diabetes Drugs Nearly Doubles

The cost of diabetes medications in the U.S. increased by 87% to $12.5 billion in 2007 from $6.7 billion in 2001, according to a study published on Monday in the Archives of Internal Medicine, Bloomberg/Boston Globe reports.

read more



Don't Forget The Men In October's Sea Of Pink
Pink is all the rage in October as money and awareness are raised for the most common cancer for women (other than skin cancer) during Breast Cancer Awareness month. But what about some attention for one of the most common cancers in men? Prostate cancer is the second leading cause of cancer death in men, according to the American Cancer Society.

November Is Pancreatic Cancer Awareness Month
According to the American Cancer Society (ACS), pancreatic cancer is the fourth leading cancer killer in the country, with over 37,000 new cases expected and more than 34,000 deaths by year's end. In New Jersey alone, an estimated 1,000 deaths are expected this year due to the disease.

Examining HIV/AIDS Situation In Philadelphia

The Philadelphia Inquirer on Tuesday examined how estimates indicate that new HIV infections in Philadelphia are occurring at a rate more than five times the national average. According to the Inquirer, the estimates, which are based on CDC data released in August, are part of a broader government strategy to slow the spread of the virus.

read more



That 'Sticky' Chromosomes Have Role In Kidney Cancer, VAI Researchers Find - Somatic Chromosome Pairing May Play Role In Other Cancers As Well
Van Andel Institute (VAI) researchers have found that when chromosomes "stick" together during the cell division process, an outcome known as somatic chromosome pairing, the result in two types of kidney cancer is disruption of a gene critical for cellular response to changes in oxygen levels. Somatic chromosome pairing may be present in other tumor types as well.

Nail Fungus - Can Nail Fungus Be Eliminated Permanently?

Nail fungus is a common problem. The fungus develops in our nail beds, the skin directly underneath our nails. The symptoms of nail fungus include discolored nails, crumbly or brittle nails, thickened nails, nails growing irregularly, and pain in the affected finger or toe. Since nail fungus is not a rare disease, many people have already contracted it without them knowing it. Only when it has advanced to a later stage do they find out about it and visit a doctor for treatment.

New Insight For Treating Vascular Disease

The blood circulates through the body in an intricate process that researchers are only beginning to understand. Now, University of Missouri researcher Steven Segal has received the National Heart, Lung and Blood Institute's prestigious Method to Extend Research in Time (MERIT) Award for his work in defining the signaling processes that control blood flow in the smallest, microscopic blood vessels, the microcirculation. Read more ...

People who take bisphosphonates for osteoporosis may be at risk for serious atrial fibrillation (AF), or irregular heartbeats, according to a new study. Read more ...

Patients who report receiving written and verbal instructions on the proper way to take the blood thinner warfarin are significantly less likely to suffer the serious gastrointestinal and brain bleeding problems that are associated with misuse of the drug, according to new research from the University of Pennsylvania School of Medicine. Read more ...